- Reuters•3 months ago
Thermo Fisher Scientific Inc reported a higher first-quarter revenue and profit, helped by strength in its life sciences unit and the world's largest maker of scientific instruments also raised its full-year forecast. The company raised its forecast to include the impact of the weakening dollar and the results of Affymetrix, which it bought last month. Thermo Fisher staved off a competing bid for Affymetrix from Origin Technologies Corp, owned by Affymetrix's former employees.
|Day's Range||0.00 - 0.00|
|Avg Vol (3m)||N/A|
As of 4:00 PM EDT. Market closed.